Literature DB >> 23463195

The origin of hepatitis C virus.

Peter Simmonds1.   

Abstract

The origin of hepatitis C virus (HCV) can be conceptualised at several levels. Firstly, origins might refer to its dramatic spread throughout the Western world and developing countries throughout the twentieth century. As a blood-borne virus, this epidemic was fuelled by new parenteral transmission routes associated with medical treatments, immunisation, blood transfusion and more recently injecting drug use. At another level, however, origins might refer to the immediate sources of HCV associated with its pandemic spread, now identified as areas in Central and West sub-Saharan Africa and South and South East Asia where genetically diverse variants of HCV appear to have circulated for hundreds of years. Going back a final step to the actual source of HCV infection in these endemic areas, non-human primates have been long suspected as harbouring viruses related to HCV with potential cross-species transmission of variants corresponding to the 7 main genotypes into humans. Although there is tempting analogy between this and the clearly zoonotic origin of HIV-1 from chimpanzees in Central Africa, no published evidence to date has been obtained for infection of HCV-like viruses in either apes or Old World monkey species. Indeed, a radical re-think of both the host range and host-specificity of hepaciviruses is now required following the very recent findings of a non-primate hepacivirus (NPHV) in horses and potentially in dogs. Further research on a much wider range of mammals is needed to better understand the true genetic diversity of HCV-like viruses and their host ranges in the search for the ultimate origin of HCV in humans.

Entities:  

Mesh:

Year:  2013        PMID: 23463195     DOI: 10.1007/978-3-642-27340-7_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  57 in total

1.  Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity.

Authors:  Miguel Angel Martinez; Maria Nevot; Ana Jordan-Paiz; Sandra Franco
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 2.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

3.  Highly divergent hepaciviruses from African cattle.

Authors:  Victor Max Corman; Adam Grundhoff; Christine Baechlein; Nicole Fischer; Anatoly Gmyl; Robert Wollny; Dickson Dei; Daniel Ritz; Tabea Binger; Ernest Adankwah; Kwadwo Sarfo Marfo; Lawrence Annison; Augustina Annan; Yaw Adu-Sarkodie; Samuel Oppong; Paul Becher; Christian Drosten; Jan Felix Drexler
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

Review 4.  The Strange, Expanding World of Animal Hepaciviruses.

Authors:  Alex S Hartlage; John M Cullen; Amit Kapoor
Journal:  Annu Rev Virol       Date:  2016-09-29       Impact factor: 10.431

5.  Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.

Authors:  Stephanie Walter; Andrea Rasche; Andrés Moreira-Soto; Stephanie Pfaender; Magda Bletsa; Victor Max Corman; Alvaro Aguilar-Setien; Fernando García-Lacy; Aymeric Hans; Daniel Todt; Gerhard Schuler; Anat Shnaiderman-Torban; Amir Steinman; Cristina Roncoroni; Vincenzo Veneziano; Nikolina Rusenova; Nikolay Sandev; Anton Rusenov; Dimitrinka Zapryanova; Ignacio García-Bocanegra; Joerg Jores; Augusto Carluccio; Maria Cristina Veronesi; Jessika M V Cavalleri; Christian Drosten; Philippe Lemey; Eike Steinmann; Jan Felix Drexler
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

6.  Hepatitis C Virus in Pregnancy and Early Childhood: Current Understanding and Knowledge Deficits.

Authors:  Ravi Jhaveri; Geeta K Swamy
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

Review 7.  Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.

Authors:  L B Dustin; B Bartolini; M R Capobianchi; M Pistello
Journal:  Clin Microbiol Infect       Date:  2016-08-31       Impact factor: 8.067

8.  Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction.

Authors:  Selena M Sagan; Peter Sarnow; Joyce A Wilson
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

Review 9.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

10.  Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America.

Authors:  Arturo Panduro; Sonia Roman
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.